news

Oggolaanshaha Aehealth BfArM

Tijaabada Aehealth 2019-nCov antigen waxay ogolaansho gaar ah ka heshay Machadka Federaalka Jarmalka ee Dawooyinka iyo Aaladaha Caafimaadka (BfArM) sida ku cad §11 cutubka 1 ee Xeerka Qalabka Caafimaadka Jarmalka (MPG) ee tijaabooyinka antigen-ka ee lagu ogaanayo coronavirus.

U hoggaansanaanta falsafada "daryeel caafimaad oo ka wanaagsan bini'aadamka", Aehealth waxay si joogto ah uga shaqaynaysay si ay u qanciso baahida caalamiga ah ee tijaabooyinka degdegga ah ee ka hortagga iyo xakamaynta masiibada adduunka oo dhan.Aehealth 2019-nCoV Antigen Test (dahab colloidal) oo lagu sameeyay muunad suuf ah oo laga soo qaaday daloolka sanka ayaa keenaya natiijooyin 15 daqiiqo gudaheed, taasoo si weyn u gaabinaysa waqtiga ogaanshaha, marka la barbar dhigo habka PCR.Tijaabadu waxay siin kartaa isticmaaleyaasha dabacsanaan sare leh natiijooyin tayo aad u wanaagsan.

Wasiirka caafimaadka Jarmalka Jens Spahn ayaa sheegay in ansixinta tijaabooyinka COVID-19 antigen ay u oggolaanayso dad badan in la baaro.Aqoonsiga hore ee shakhsiyaadka asymptomatic-ka ah ayaa si hufan u jebin kara silsiladda caabuqa, joojinta faafitaanka caabuqa.

Tijaabada degdega ah ee COVID-19 Antigen test waa immunochromatography dahab kolloidal ah oo loogu talagalay in lagu ogaado tayada antigens-ka nucleocapsid ee COVID-19 ee sanka sanka ee bini'aadamka, suufka dhuunta ama candhuufta shaqsiyaadka looga shakisan yahay COVID-19 bixiyehooda daryeel caafimaad.

Novel coronaviruses waxay iska leeyihiin genus β.COVID-19 waa cudur faafa oo neef-mareenka oo degdeg ah.

Natiijooyinka waa aqoonsiga COVID-19 nucleocapsid antigen.Antigen-ka guud ahaan waxaa lagu ogaan karaa sambabada neef-mareenka sare ama sambabada neefsashada hoose inta lagu jiro marxaladda ba'an ee caabuqa.

Natiijooyinka wanaagsani waxay muujinayaan joogitaanka antigens fayras, laakiin xidhiidhka kiliinikada ee taariikhda bukaanka iyo macluumaadka kale ee ogaanshaha waa lagama maarmaan si loo go'aamiyo heerka caabuqa.

Natiijooyinka wanaagsani kama saarayaan infekshanka bakteeriyada ama caabuqa fayrasyada kale.Antigen-ka la ogaaday ma noqon karo sababta dhabta ah ee cudurka.

Natiijooyinka taban kama saarayaan COVID-19 caabuq oo waa inaan loo isticmaalin saldhigga keliya ee daaweynta ama go'aamada maareynta bukaanka, oo ay ku jiraan go'aamada xakameynta caabuqa.

Natiijooyinka taban waa in lagu tixgaliyaa macnaha guud ee soo-bandhigidda bukaanka, taariikhda iyo joogitaanka calamadaha caafimaad iyo calaamadaha la socda COVID-19 oo lagu xaqiijiyo baaritaanka moecular, haddii loo baahdo maaraynta bukaanka.

Maaddaama ay tahay shirkadda haysata shahaadooyinka tijaabada antigen-ka ee 2019-nCoV, Aehealth waxaa ka go'an inay wax ku biiriso dagaalka caalamiga ah ee ka dhanka ah masiibada.Tijaabooyinka badan ee Aehealth ee COVID-19 waxay gaadheen oggolaanshaha calaamadda CE waxaana ansixiyay waddanka soodejiyaha sida waafaqsan heerarka iyo xeerarka maxalliga ah.Aehealth waxay hadda bixinaysaa "PCR+ Antigen+Deutralization Antibody" xal isku dhafan oo buuxiya xaalado kala duwan oo codsi ah oo isla markiiba lagu ogaado caabuqa COVID-19.


Waqtiga boostada: Dec-12-2021